Back to Annual Meeting

Back to Annual Meeting

APHA Scientific Session and Event Listing

Recorded presentation

Charlene Le Fauve, PhD, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, 1 Choke Cherry Road, #5-1043, Rockville, MD 20850, 240.276.2787, charlene.lefauve@samhsa.hhs.gov

[Part of session: “Co-occurring substance use and mental disorders: Epidemiology, policy, practice, and costs.” Charlene Le Fauve, organizer, charlene.lefauve@samhsa.hhs.gov., abstract # 139244]

At least 4.2 million Americans 18 and older have co-occurring substance use and mental disorders. Nearly half receive no treatment for either disorder and only 6 percent receive treatment for both disorders. A priority of the Substance Abuse and Mental Health Services Administration (SAMHSA) is the improvement of services for persons with co-occurring disorders. In 2002, SAMHSA submitted the “Report to Congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders,” describing the epidemiology of co-occurring disorders, the limitations of the current service system to meet the needs of persons with such disorders, and the principal of “any door is the right door.” In 2005, SAMHSA published “Tip 42: Substance abuse treatment for persons with co-occurring disorders,” a compendium for the treatment field of the epidemiology and nature of co-occurring disorders, and of evidence-based approaches for treating persons with these disorders. SAMHSA conducts “Co-Occurring Policy Academies” to enable states to develop plans to improve their service systems, and offers “Co-Occurring State Incentive Grants (COSIG)” to provide financial support to states wanting to improve their service systems. This presentation will describe the essential elements of the Report to Congress and the Tip 42, highlight lessons learned to date from the Policy Academies and COSIG states, and emphasize the importance of effective screening, assessment, and treatment coordination for persons with co-occurring disorders.

Learning Objectives: At the conclusion of the presentation, participants will be able to

• Describe the essential elements of the SAMHSA's Report to Congress on the Prevention and Treatment of Co-Occurring Substance Abuse and Mental Disorders.
• Describe the essential elements of SAMHSA's Tip 42
  Substance abuse treatment for persons with co-occurring disorders.
  • List the purposes of SAMHSA's Co-occurring State Incentive Grant program.
  • Describe the importance of screening, assessment, and treatment planning in serving persons with co-occurring disorders.

  Keywords: Substance Abuse Treatment, Mental Health System

  Presenting author's disclosure statement:

  Any relevant financial relationships? No
  

  Recorded presentation

  Co-Occurring Substance Use and Mental Disorders: Epidemiology, Policy, Practice, and Costs

  The 134th Annual Meeting & Exposition (November 4-8, 2006) of APHA